tiprankstipranks
Immunovant, Inc. (IMVT)
NASDAQ:IMVT
US Market
IMVT
Immunovant
RESEARCH TOOLSreports
Want to see IMVT full AI Analyst Report?

Immunovant (IMVT) Stock News & Sentiment

942 Followers
This Is Why Immunovant Stock (IMVT) Is Up Today
Premium
Market News
This Is Why Immunovant Stock (IMVT) Is Up Today
13h ago
IMVT
Insiders Dump Shares in Global-e, EyePoint, Immunovant, Nerdy, Argan
Premium
Weekend Updates
Insiders Dump Shares in Global-e, EyePoint, Immunovant, Nerdy, Argan
26d ago
AGX
EYPT
Elbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up
Premium
Weekend Updates
Elbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up
1M ago
SG
VOR
Strengthening the Buy Case for IMVT-1402: Targeted Phase 3 Graves’ Disease Strategy and Reproducible Efficacy Support Commercial Potential
Premium
Ratings
Strengthening the Buy Case for IMVT-1402: Targeted Phase 3 Graves’ Disease Strategy and Reproducible Efficacy Support Commercial Potential
1M ago
IMVT
Buy Rating Maintained on Immunovant as IMVT-1402 Pipeline Overshadows Batoclimab Setback
Premium
Ratings
Buy Rating Maintained on Immunovant as IMVT-1402 Pipeline Overshadows Batoclimab Setback
2M ago
IMVT
Undervalued Potential in Difficult-to-Treat RA: Buy Rating on Immunovant Driven by IMVT-1402’s Differentiated Profile and Underappreciated Market Opportunity
Premium
Ratings
Undervalued Potential in Difficult-to-Treat RA: Buy Rating on Immunovant Driven by IMVT-1402’s Differentiated Profile and Underappreciated Market Opportunity
3M ago
IMVT
Immunovant Rides Brepocitinib Momentum Into 2026
Premium
Company Announcements
Immunovant Rides Brepocitinib Momentum Into 2026
3M ago
IMVT
More IMVT News >

IMVT News on the Web

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Immunovant (IMVT) and Biogen (BIIB)
TipRanks News
Bullish
Immunovant price target raised to $32 from $29 at Goldman Sachs
TipRanks News
Neutral
Why Immunovant Stock Is Surging Back Today
TipRanks News
Bullish
Elbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up
TipRanks News
Bearish
Top Immunovant Executives Quietly Unload a Wave of Company Stock
TipRanks News
Neutral
Immunovant Stock Sinks After Trial Setback Shocks Wall Street
TipRanks News
Neutral
Strengthening the Buy Case for IMVT-1402: Targeted Phase 3 Graves’ Disease Strategy and Reproducible Efficacy Support Commercial Potential
TipRanks News
Neutral
Why Immunovant Shares Are Suddenly Rebounding Again
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
IMVT
Sector Average
Media Buzz
This Week10 articles
Weekly Average1.25 articles
News Sentiment
This Week83%
Sector Average76%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IMVT’s Media Buzz Sentiment?
10 articles about IMVT were published this week. In an average week, 1.25 articles are published.
    What is IMVT’s weekly average amount of articles?
    In an average week, 1.25 articles about IMVT are published.
      What is IMVT’s News Sentiment?
      83% of articles about IMVT were positive this week, compared to its sector average of 76%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        CGENCompugen
        PROKProKidney
        ROIVRoivant Sciences
        Showing the stocks with the most bullish news sentiment over the past week